Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using a smartphone app to help manage cravings in people with addictions

Official title: Efficacy of a Smartphone App Designed to Manage Craving and Individual Predictors of Substance Use / Addictive Behavior Among Individuals With Addictive Disorders

Run by Centre Hospitalier Charles Perrens, Bordeaux · NCT04732676 · Data updated 2026-11-12

This study tests whether a smartphone app can help people with addictions manage their cravings and reduce their substance use.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment274 (estimated)
SponsorCentre Hospitalier Charles Perrens, Bordeaux
Government
Locations1 site (Bordeaux)
StatusRecruiting
StartedMarch 1, 2023
Main results expectedDecember 31, 2027
Study endsJuly 31, 2028
Registry record updatedAugust 14, 2025
Trial IDNCT04732676 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older who are seeking help for substance or behavioral addictions and can commit to using the app.

Probably not a fit

Patients with immediate medical or psychiatric needs, or those unable to use a smartphone, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project evaluates the effectiveness of a smartphone application designed to assist individuals struggling with substance use and behavioral addictions. Developed by the University of Bordeaux's Sanpsy Lab, the app aims to manage cravings and identify individual predictors of addictive behavior. Participants will be recruited from specialized addiction treatment centers and will use the app to help reduce or stop their substance use. The application also monitors concurrent substance use to prevent addiction transfers.

Why it matters

Potential benefit: If successful, this app could provide a convenient and personalized tool for individuals seeking to manage their cravings and reduce addictive behaviors.

How similar studies have gone: Previous studies have shown promise in using technology to support addiction treatment, but this specific approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants requesting help for substance or behavioral addiction in one of the participating specialized addiction treatment centers, and with more than 1-month-delay before treatment admission
* Age \>= 18 years of age
* With at least one substance or behavioral addiction (DSM-5 criteria)
* Affiliated person or beneficiary of a social security scheme.
* Free, informed and written consent signed by the participant and the investigator

Exclusion Criteria:

* Medical, psychiatric or addiction condition that warrants immediate treatment intervention
* Patients with somatic, cognitive or other disorders preventing the use of the device (deafness, impaired vision, illiteracy....)
* Difficulty in understanding and / or writing French
* Not familiar with the use of smartphone
* Individuals participating in another study that includes an ongoing exclusion period
* Be deprived of liberty due to an ongoing legal procedure
* Individuals under legal protection
* Be under guardianship or under curatorship

Where it's running

  • Centre Hospitalier Charles PERRENS
    Bordeaux, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.